r = 3.19 − 0.101 (age) + 0.147 (albumin) + 0.0165 (change in bilirubin) − 0.206 (renal insufficiency) − 0.0065 (baseline bilirubin) − 0.0096 (PT) Responder: Lille <0.45 [Creatinine ≥115 µmol/l, renal ...

Research scientists from the Indiana University School of Medicine and Regenstrief Institute have found that individuals with a parent who died from liver disease face more than double the risk of ...

Severe alcohol-associated hepatitis (sAH) remains a highly lethal condition with limited therapeutic options. Characterized by rapid liver decompensation, sAH is often accompanied by acute kidney ...

Please provide your email address to receive an email when new articles are posted on . Hispanic patients with AUD had higher odds of alcohol-associated hepatitis, decompensated cirrhosis and related ...

Research scientists from the Indiana University School of Medicine and Regenstrief Institute have found that individuals with a parent who died from liver disease face more than double the risk of ...

Please provide your email address to receive an email when new articles are posted on . Rates of alcohol-associated hepatitis increased from 2002 to 2021 among adolescents and young adults in Ontario, ...

There's another health crisis unfolding simultaneously alongside COVID-19. Alcohol abuse has reached the most extreme point in an increasing number of people. “We've definitely noticed an increase in ...

Alcohol use has been on the rise during the coronavirus pandemic. Landree Sarata was just 31 years old when she was diagnosed with end-stage liver failure after drinking nearly daily for the past ...

Adding fecal microbiota therapy to standard care for steroid-ineligible severe alcoholic-associated hepatitis appeared safe and effective in a small randomized trial from India. Survival at 90 days ...

Hepatitis is an inflammation of the liver. It’s considered acute until it lasts six months, at which point it’s considered chronic. Complications that can develop from chronic hepatitis include a ...

Evaluation of novel therapies for severe AH remains an active area of research and to provide an insight into forthcoming studies and those currently in progress, the authors searched US and EU ...